Xlife Sciences AG (SWX: XLS)
Switzerland
· Delayed Price · Currency is CHF 25.00
-0.40 (-1.57%)
Jan 3, 2025, 9:00 AM CET
Xlife Sciences AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 21.24 | 14.88 | 14.31 | 53.42 | 21.46 | 1.05 |
| Depreciation & Amortization | 16.03 | 16.03 | 16.02 | 0.07 | 0.06 | 0.02 |
| Loss (Gain) From Sale of Assets | -18.43 | -18.43 | - | - | - | - |
| Asset Writedown & Restructuring Costs | 0 | 0 | 0 | - | - | - |
| Loss (Gain) From Sale of Investments | -21.41 | -15.88 | -34.76 | -59.92 | -24.31 | -1.25 |
| Loss (Gain) on Equity Investments | 7.8 | 7.8 | - | - | - | - |
| Other Operating Activities | 1.59 | 0.39 | 0.94 | 3.01 | 2.81 | 1.44 |
| Change in Accounts Receivable | -8.41 | -8.58 | -0.26 | -0.06 | 2.22 | -2.04 |
| Change in Accounts Payable | 0.11 | 0.34 | 0.25 | 0.04 | 0.06 | 0.4 |
| Change in Unearned Revenue | 2.67 | 2.88 | -1 | - | -2.66 | 0.05 |
| Change in Other Net Operating Assets | 0.72 | 0.74 | -0.1 | -0.88 | -0.04 | -0.07 |
| Operating Cash Flow | 1.91 | 0.17 | -4.61 | -4.32 | -0.4 | -0.4 |
| Capital Expenditures | -0.01 | -0.01 | -0.02 | -0.16 | -0.03 | -0.02 |
| Cash Acquisitions | -0.67 | -0.67 | -0.11 | -1.78 | -0.07 | -0.02 |
| Sale (Purchase) of Intangibles | -0.03 | -0.03 | -0.06 | -1.06 | -0.19 | - |
| Investment in Securities | -3.29 | - | - | -1.84 | -2.78 | -3.63 |
| Other Investing Activities | -0.45 | -0.3 | -1.49 | -2.2 | -0.79 | -1.62 |
| Investing Cash Flow | -4.44 | -1.01 | -1.68 | -7.03 | -3.86 | -5.29 |
| Short-Term Debt Issued | - | 0.84 | - | - | - | - |
| Total Debt Issued | 1.07 | 0.84 | - | - | - | - |
| Long-Term Debt Repaid | - | -0.11 | -0.11 | -0.03 | -0.05 | -0.02 |
| Net Debt Issued (Repaid) | 2.01 | 0.73 | -0.11 | -0.03 | -0.05 | -0.02 |
| Issuance of Common Stock | 0.11 | 0.11 | 5.01 | 9.36 | 7.06 | 8.38 |
| Other Financing Activities | -0.01 | -0.01 | -0.35 | -0.73 | -0.57 | -0.14 |
| Financing Cash Flow | 2.11 | 0.83 | 4.56 | 8.6 | 6.43 | 8.22 |
| Foreign Exchange Rate Adjustments | 0.01 | 0.01 | 0 | 0.02 | -0 | 0 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | 0 | - | - |
| Net Cash Flow | -0.41 | -0 | -1.74 | -2.75 | 2.16 | 2.54 |
| Free Cash Flow | 1.9 | 0.16 | -4.62 | -4.48 | -0.43 | -0.42 |
| Free Cash Flow Margin | 191.82% | 15.97% | -449.70% | -555.74% | -108.75% | -82.20% |
| Free Cash Flow Per Share | 0.23 | 0.02 | -0.64 | -0.72 | -0.07 | -0.12 |
| Cash Interest Paid | 0.13 | 0.08 | 0.26 | 0.22 | 0.17 | - |
| Cash Income Tax Paid | 0.05 | 0.05 | 0.08 | 0.02 | 0.04 | 0.02 |
| Levered Free Cash Flow | -9.73 | -10.47 | 1.52 | -4.97 | 3.01 | - |
| Unlevered Free Cash Flow | -9.54 | -10.23 | 1.95 | -4.66 | 3.13 | - |
| Change in Net Working Capital | 14.15 | 13.82 | 1.02 | 1 | -4.8 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.